CDB15:0000938 INHBB — ACVR1B

Experimentally validated in Human, Mixed species; Orthology-inferred in Human, Mouse, Rat, Frog, Zebrafish, Chicken, Macaque, Pig, Dog, Cow, Chimp, Horse, Marmoset, Sheep

Title

Journal:; Year Published:

Abstract

Modulation of activin signal transduction by inhibin B and inhibin-binding protein (INhBP).

Molecular endocrinology, 2001; PubMed, Homo sapiens INHBB — Homo sapiens ACVR1B
ABSTRACT: An antagonistic relationship between inhibin and activin is essential to the control of pituitary FSH release and to normal gonadal function. Two inhibin ligands, inhibin A and inhibin B, are made by the ovary in females, and each regulate pituitary FSH at different times during the reproductive cycle. Inhibin B, but not inhibin A, is produced by the testes and is therefore responsible for all inhibin-dependent FSH regulation in males. Although the activin signal transduction pathway has been well characterized, little is known about the mechanism of inhibin signaling and its relationship to activin antagonism. A recently cloned inhibin-binding protein, InhBP (p120), associates strongly with the type IB activin receptor (Alk4) in a ligand-responsive manner and interacts to a lesser extent with other activin and bone morphogenetic protein (BMP) type I and activin type II receptors. Activin stimulates the association of InhBP and Alk4, and inhibin B, but not inhibin A, interferes with InhBP-Alk4 complex formation. InhBP is necessary to mediate a specific antagonistic effect of inhibin B on activin-stimulated transcription. Appropriate stoichiometry between InhBP and the activin type I receptor is crucial to InhBP function. These findings suggest that InhBP is an inhibin B-specific receptor that mediates antagonism of activin signal transduction through the modulation of activin heteromeric receptor complex assembly.

Activin isoforms signal through type I receptor serine/threonine kinase ALK7.

Molecular and cellular endocrinology, 2004; PubMed, Bos taurus INHBB — Homo sapiens ACVR1B
ABSTRACT: Activins play a fundamental role in cell differentiation and development. Activin A signaling is mediated through a combination of activin type II receptors (ActRIIs) and the activin type IB receptor, ALK4. Signaling receptors of other activin isoforms remain to be elucidated. Here, we found that activin AB and activin B are ligands for ALK7. ALK7 is an orphan receptor serine/threonine kinase expressed in neuroendocrine tissues including pancreatic islets. The combination of ActRIIA and ALK7, preferred by activin AB and activin B but not by activin A, is responsible for activin-mediated secretion of insulin from pancreatic beta cell line, MIN6. In contrast, all activins activate a combination of ActRIIA and ALK4 with various levels of potency. Thus, variation in activin signaling through type I receptors is dependent upon homo- and heterodimeric assembly of activin isoforms. Thus, the differential combination of receptor heterodimers mediates variation in activin isoform signaling.
Basic Information on INHBB
Ligand Name: inhibin subunit beta B
Other Symbols: N/A
Ligand Location: secreted based on hpa, perplexity, uniprot
HGNC Gene Symbol Report: INHBB
GeneCards: INHBB
Interactions with other Receptors for INHBB
Basic Information on ACVR1B
Receptor Name: activin A receptor type 1B
Other Symbols: ACVRLK4, ALK4, SKR2, ActRIB
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: ACVR1B
GeneCards: ACVR1B
HGNC Gene Group: Receptor kinases